Answers are grounded in this paper and cite their sources.
Herein we unveil that HIF-1α directly regulates WNT7A expression during myogenesis. In fact, chromatin immunoprecipitation and site-directed mutagenesis experiments revealed two distinct Hypoxia Response Elements (HREs) that are specific HIF-1α binding sites on the WNT7A promoter. Remarkably, a pharmacological activation of HIF-1α induced WNT7A expression and enhanced muscle differentiation. On the other hand, silencing of WNT7A using CRISPR/Cas9 genome editing blocked the effects of HIF-1α activation on myogenesis. Finally, treatment with prolyl hydroxylases inhibitors improved muscle regeneration in vitro and in vivo in a CTX-induced muscle injury mouse model, paving the way for further studies to test its efficacy on acute and chronic muscular pathologies.
No takes yet. Share an insight, caveat, or question.
Cirillo et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: